BIRC5 and cancer: Inhibitor of apoptosis (IAP) proteins that include cIAP1 (cellular inhibitor of apoptosis protein-1), cIAP2, XIAP (X-linked inhibitor of apoptosis protein), and survivin promote survival of cancer cells by inhibiting apoptosis and have been proposed to be therapeutic targets in cancer [42,43].